Telemedicine in Latin America during COVID-19

On February 26th, 2020, Latin Americans ceased to be coronavirus spectators and began enduring its effects in their own flesh. Since then, a fragile and unprepared healthcare system for a pandemic has been exposed. As a result, initiatives such as telemedicine have gained strength and have been positioned as an alternative to traditional medicine. Telemedicine…

COVID19 clinical research challenges and opportunities

On May 20th, the International Clinical Trials Day was celebrated.  It was on January 1922 when Leonard Thompson, a 14-year-old diabetic who was about to die at Toronto General Hospital, was the first receiving insulin, discovered by scientists Frederick Grant Banting and Charles Herber Best. Day by day, after administering the medicine, the miraculous recovery…

Innovation in Times of COVID-19

On March 25, 2020, a consortium of life science companies with  the Bill & Melinda Gates Foundation announced a collaboration to promote the development, manufacture, and delivery of diagnostics and treatments to combat COVID-19.  With extensive years of expertise in the healthcare sector and the pharmaceutical research, these expert companies will raise financial aid and…

Lead Vaccine Candidate for COVID-19

Johnson & Johnson announces an important finding in the fight against COVID-19!  As a result of its efforts in pharmaceutical research and innovation, this company announced that it will begin the phase of human clinical studies at the latest by September 2020.  This good news would mean an achievement in vaccine development, compared to the…

Coronavirus

Coronavirus, pharmaceutical research and global health

The Coronavirus outbreak (2019-nCoV) was  declared a pandemic by the Director-General of the World Health Organization (WHO), responding to the rapid spread of this pathology. This statement shows the dangerous nature of the virus, and the need to find effective treatments and strengthen available healthcare systems, especially in Latin America, which has already started reporting…

APEC Webinar: Opportunities for Latam

On January 21st, FIFARMA organized the Webinar entitled: APEC: Opportunities for Latam. This virtual talk discussed the opportunities in Latin America in regulatory training issues, especially in recent years. Our Executive Director Rafael Andrés Díaz-Granados moderated and opened this talk. APEC unveiled convergence and regulatory training opportunities for the region. The steering committee for harmonization…

IFPMA assumes its immunization role with two new reports

The International Federation of Manufacturers and Associations of Pharmaceutical Products (IFPMA) recently published two reports that contribute to research, development, implementation and dissemination of information on vaccines and immunization -essential topics in the improvement of global health. One of them is The complex journey of a vaccine, a report dealing with the process of developing…